4.8 Article

DODAG; a versatile new cationic lipid that mediates efficient delivery of pDNA and siRNA

Journal

JOURNAL OF CONTROLLED RELEASE
Volume 143, Issue 2, Pages 222-232

Publisher

ELSEVIER
DOI: 10.1016/j.jconrel.2009.12.001

Keywords

Cationic lipids; Nucleic acid delivery; Liposomes; Nanoparticles; Guanidinium lipids; Polyamines; Transfection; RNA interference

Funding

  1. EPSRC
  2. ImuThes Ltd
  3. Mitsubishi Chemical Corporation
  4. South African Innovation Fund
  5. National Research Foundation
  6. European Union [LSHB-CT-2004-005276]
  7. CANSA
  8. South African Poliomyelitis Research Foundation
  9. Engineering and Physical Sciences Research Council [EP/F003188/1] Funding Source: researchfish
  10. EPSRC [EP/F003188/1] Funding Source: UKRI

Ask authors/readers for more resources

We report the syntheses of novel cationic lipids comprised of cholesteryl-moieties linked to guanidinium functional groups, and also cationic lipids comprising a dialkylglycylamide moiety conjugated with a polyamine or a guanidinium functional group. In plasmid DNA (pDNA) transfection studies, these cationic lipids were formulated into cationic liposomes with the neutral co-lipid dioleoyl-L-alpha-phosphatidylethano-lamine (DOPE) or with a recently reported neutral lipophosphoramidate derivative of histamine (MM27). We observe that cationic liposomes prepared from the cationic lipid N',N'-dioctadecyl-N-4,8-diaza-10-aminodecanoylglycine amide (DODAG) and DOPE frequently mediate the highest levels of transfection in vitro in all three different cell lines studied (OVCAR-3, IGROV-1 and HeLa) both in the presence or absence of serum. In addition, in vitro cellular toxicity was found to be minimal. Alternatively, we observe that DODAG alone forms lipoplex nanoparticles with small interfering RNA (siRNA) that are able to mediate the functional delivery of two previously validated anti-hepatitis B virus (HBV) - siRNAs to murine liver in vivo with minimal observable liver toxicity and immune stimulation. Specific knock-down of HBV infection parameters (virion and hepatic mRNA levels) is observed that is at least equivalent to the impact of extensive treatment with lamivudine (a licensed antiviral drug). (C) 2009 Elsevier B.V. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available